Lokelma

Active Ingredient(s): Sodium Zirconium Cyclosilicate
FDA Approved: * May 18, 2018
Pharm Company: * ASTRAZENECA PHARMS
Category: Potassium Levels

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Lokelma Overview

Sodium zirconium cyclosilicate (ZS-9), sold under the brand name Lokelma, is a medication used to treat high blood potassium.[1] Onset of effects occurs in one to six hours.[1] It is taken by mouth.[1] Common side effects include swelling and low blood potassium.[1] Use is likely safe in pregnancy and breastfeeding.[1] It works by binding potassium ions in the gastrointestinal tract which is then lost in the stool...

Read more Lokelma Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Sodium_zirconium_cyclosilicate

Recent Lokelma Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Sodium Zirconium Cyclosilicate
  • For Suspension: 10gm/packet, 5gm/packet
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Lokelma: (2 results)

Sorted by National Drug Code
  • 0310-1105 Lokelma 5 g/5g Oral Powder, for Suspension by Astrazeneca Pharmaceuticals Lp
  • 0310-1110 Lokelma 10 g/10g Oral Powder, for Suspension by Astrazeneca Pharmaceuticals Lp

Other drugs which contain Sodium Zirconium Cyclosilicate or a similar ingredient: (1 result)